[ASK1-MAP kinase signaling pathway as a therapeutic target for human diseases]

Insights

Apoptosis signal-regulating kinase 1 (ASK1) is a stress-activated kinase crucial for cellular responses. This review explores ASK1

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Biochemistry

Context:

  • Apoptosis signal-regulating kinase 1 (ASK1), a member of the MAPK kinase kinase family, is activated by cellular stresses like ROS, TNF-alpha, LPS, and ER stress.
  • ASK1 plays critical roles in cellular processes including apoptosis, differentiation, and inflammation.
  • Dysregulation of ASK1-MAPK signaling is implicated in various human diseases.

Purpose:

  • To provide a comprehensive overview of the current understanding of ASK1.
  • To highlight the significance of the ASK1-MAPK signaling pathway in human diseases.
  • To evaluate ASK1 as a potential therapeutic target for treating human diseases.

Summary:

  • ASK1 is a key kinase activated by diverse cellular stresses.
  • Its signaling pathway is integral to fundamental cellular functions.
  • Recent research underscores ASK1's involvement in stress-response-related human pathologies.

Impact:

  • Understanding ASK1's role in stress responses offers insights into disease mechanisms.
  • Identifying ASK1 as a therapeutic target opens avenues for novel treatment strategies.
  • This review consolidates current knowledge, guiding future research in ASK1-related diseases.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.3K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
4.4K